Reuters
@Reuters·4.2M subscribers·86.9K videos
Kenvue stock rebounds as Trump's Tylenol claims face pushback | REUTERS
Posted
September 23, 2025
Views
5,999
Likes
59
Engagement
0.98%
September 23, 2025
5,999
59
0.98%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:38Now PlayingTylenol-maker Kenvue's shares jumped 7% after hitting a record low, as analysts noted no new scientific evidence backed President Trump’s claim linking Tylenol use in pregnancy to autism. Regulators stress no proven causal link.
#News #Reuters #Newsfeed #tylenol #kenvue #trump #autism #pregnancy
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
